This site is intended for healthcare professionals
News

Gilead announces results from phase III trial of remdesivir in patients with moderate COVID-19.- Gilead Sciences.

Read time: 1 mins
Last updated:2nd Jun 2020
Published:2nd Jun 2020
Condition: Coronavirus/COVID-19 Infection
Type: drug
Register free for full access to medthority.com